Systems and Methods for Bedding with Sleep Diagnostics
US-2015320354-A1 · Nov 12, 2015 · US
Method for the treatment of acquired lymphedema
US8965708B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8965708-B2 |
| Application number | US-201113136372-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 28, 2011 |
| Priority date | Feb 17, 2006 |
| Publication date | Feb 24, 2015 |
| Grant date | Feb 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention identifies genes whose gene products are differentially expressed in lymphedema tissues, particularly cutaneous tissue involved in whole organ response to lymphedema. The invention provides methods for diagnosing or assessing an individual's susceptibility to lymphedema. Also provided are therapeutic methods for treating a patient or methods for prophylactically treating an individual susceptible to lymphedema. Additionally, the invention describes screening methods for identifying agents that can be administered to treat individuals that have or at risk of developing lymphedema.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for the treatment of acquired lymphedema in a subject, the method comprising: administering ketoprofen or a derivative thereof to a subject having acquired lymphedema in an amount effective to reduce volume of the lymphedema in said subject. 2. The method according to claim 1 , wherein said administering comprises topical administration. 3. The method according to claim 1 , wherein said method further compris…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
- A61B5/411Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8965708B2 cover?
- The present invention identifies genes whose gene products are differentially expressed in lymphedema tissues, particularly cutaneous tissue involved in whole organ response to lymphedema. The invention provides methods for diagnosing or assessing an individual's susceptibility to lymphedema. Also provided are therapeutic methods for treating a patient or methods for prophylactically treating a…
- Who is the assignee on this patent?
- Tabibiazar Raymond, Rockson Stanley G, Univ Leland Stanford Junior
- What technology area does this patent fall under?
- Primary CPC classification A61B5/411. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).